INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?
AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
Cutting Corners In RTSM Software Increases Speed...And RISK!
Discover why true RTSM efficiency requires rigor, not shortcuts — highlighting how thoughtful processes and clear communication deliver speed without compromising quality or introducing avoidable risk.
-
Biotech Delivers A Superior Patient And Site Experience
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
Own Your Data, Accelerate Your Cure5/6/2026
Move from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.
-
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape1/22/2025
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
-
eCOA Standards And KPIs To Include In Your Next RFI3/9/2026
Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 20242/11/2025
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
Letter From The CEO: A New Era Of Drug Development Is Here9/3/2024
This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.
-
Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.
-
As industry experts in DCT, MRN has delivered innovative solutions using our specialized expertise and creative approaches, providing in-home clinical trial visits through their Home Trial Support service to over 230 trials.
-
Streamline your clinical trial study creation by automating and accelerating the eCOA build process. Generative AI models perform your repetitive configurations and significantly shorten build times.
-
Explore how this platform of oncology solutions integrates advanced technologies to streamline oncology trials, enhancing efficiency, patient engagement, regulatory compliance, and data accuracy.